It was hypothesized that the presence of A-allele, linked to increased gene expression of ACE2, resulting in higher ACE2 serum levels, and therefore and an increased number of viral binding sites, could increase COVID-19 severity [19,21]. This evidence concerns the gene ACE2 and COVID-19.